Our NOA has arrived for an R03 to investigate the role of cerebral amyloid angiopathy as a potential link between brain injury and increased dementia risk. Dr. Benedict Albensi (NSU Pharm Sci) and Dr. William Kochen (NSU Neuroscience) are co-investigators on this 2-year, $308,000 grant.